Current Filters

Showing 71 - 80 results of 3322

Midostaurin (Rydapt) for Systemic Mastocytosis (Rydapt) (Last Updated: Apr 20, 2020)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Rydapt
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Submission Type:
Initial

ustekinumab (Stelara/Stelara I.V) (Last Updated: Sep 16, 2020)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Stelara/Stelara I.V
Manufacturer:
Janssen Inc.
Submission Type:
Initial
Indications:

Ulcerative colitis

New at CADTH — July 2019 (Last Updated: Jul 10, 2019)

News and Events CADTH is pleased to announce the membership of its new Patient and Community Advisory Committee. Learn more about the committee and its members here. Drug Reimbursement Recommendations...
Project Line:
New at CADTH
Download results as CSV